Get started
Author

Jamil Aliyu Galadanci

Observed names: Jamil A. Galadanci, Jamil Galadanci
ORCID: 0009-0006-4724-3992
Observed ORCID: 0009-0006-4724-3992
OpenAlex ID: A5066870402
Men with sickle cell disease experience greater sexual dysfunction when compared with men without sickle cell disease
2020 · Ibrahim M. Idris, Akib Abba, et al. · Blood Advances · 49
Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria
2019 · Aisha A. Galadanci, Najibah A. Galadanci, et al. · American Journal of Hematology · 19
PDF
Incidence and predictors of priapism events in sickle cell anemia: a diary-based analysis
2022 · Ibrahim M. Idris, Akib Abba, et al. · Blood Advances · 15
PDF
Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework
2021 · Djamila L. Ghafuri, Shehu U. Abdullahi, et al. · Journal of Pediatric Hematology/Oncology · 14
Psychometric Impact of Priapism on Lives of Adolescents and Adults With Sickle Cell Anemia: A Sequential Independent Mixed-Methods Design
2021 · Ibrahim M. Idris, Kemberlee Bonnet, et al. · Journal of Pediatric Hematology/Oncology · 14
A Beowulf Cluster for Teaching and Learning
2015 · Ahmad A. Datti, Hadiza A. Umar, et al. · Procedia Computer Science · 14
PDF
Psychometric Impact of Priapism on Lives of Adolescents and Adults With Sickle Cell Anemia: A Sequential Independent Mixed-Methods Design.
2022 · Ibrahim M Idris, Kemberlee Bonnet, et al. · PubMed · 9
A controlled trial for preventing priapism in sickle cell anemia: hydroxyurea plus placebo vs hydroxyurea plus tadalafil
2025 · Ibrahim M. Idris, Aminu A. Yusuf, et al. · Blood · 7
Randomized Controlled Trial of Fixed Low-Vs Moderate-Dose Hydroxyurea for Primary Stroke Prevention in Sub-Saharan Africa: Final Results of the Spring Trial
2020 · Shehu Umar Abdullahi, Binta W. Jibir, et al. · Blood · 6
Cross Sectional Survey of Priapism and Sexual Dysfunction in 353 Men with Sickle Cell Disease
2019 · Ibrahim Musa Idris, Jamil Aliyu Galadanci, et al. · Blood · 2
Initial low and moderate dose of hydroxyurea has a durable impact on primary stroke prevention in low-income settings
2026 · Shehu U. Abdullahi, Najibah A. Galadanci, et al. · Blood Advances · 1
PDF
Randomized Controlled Double Blind Feasibility Trial of Tadalafil with Hydroxyurea Versus Hydroxyurea with Placebo for Secondary Prevention of Recurrent Priapism in Men with Sickle Cell Anemia: Pin Trial Final Results
2023 · Ibrahim Musa Idris, Aminu Abba Yusuf, et al. · Blood · 1
Progressive Silent Cerebral Infarcts Are Prevalent in Adults with Sickle Cell Anemia but Moderate-Severe Cognitive Abnormalities Are Independent of Preexisting Silent Cerebral Infarcts
2022 · Ibrahim Musa Idris, Dalha H Gwarzo, et al. · Blood · 1
Rationale and Design of a Randomized Controlled Double-Blind Internal Pilot Trial for Prevention of Recurrent Ischemic Priapism in Men with Sickle Cell Disease (PIN Trial)
2022 · Ibrahim Musa Idris, Aminu Abba Yusuf, et al. · Blood
Works count: 14
Citation count: 152
H-index: 7
I10-index: 6
Year
Topic
Type